Syntegon has launched the MLD Advanced, a filling machine for ready-to-use nested syringes that integrates technologies from ...

The acquisition also adds high potent vial filling with lyophilization, making PCI one of very few US-based CDMOs capable of producing the emerging oncology modality of antibody-drug conjugates ...

Curia's sterile fill-finish facility in Glasgow will add an integrated, isolator-based vial filling line and lyophilizer suitable for a broad range of drug product including highly potent capabilities ...